0001994702-23-000001.txt : 20231107 0001994702-23-000001.hdr.sgml : 20231107 20231106195342 ACCESSION NUMBER: 0001994702-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231107 DATE AS OF CHANGE: 20231106 EFFECTIVENESS DATE: 20231107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kyverna Therapeutics, Inc. CENTRAL INDEX KEY: 0001994702 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 831365441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-496597 FILM NUMBER: 231381223 BUSINESS ADDRESS: STREET 1: 5980 HORTON STREET STREET 2: SUITE 550 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5106268331 MAIL ADDRESS: STREET 1: 5980 HORTON STREET STREET 2: SUITE 550 CITY: EMERYVILLE STATE: CA ZIP: 94608 D 1 primary_doc.xml X0708 D LIVE 0001994702 Kyverna Therapeutics, Inc. 5980 HORTON STREET SUITE 550 EMERYVILLE CA CALIFORNIA 94608 5106268331 DELAWARE Bait Therapeutics, Inc. None Corporation true Peter Maag 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Executive Officer Director Dominic Borie 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Executive Officer James Chung 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Executive Officer Karen Walker 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Executive Officer Ryan Jones 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Executive Officer Steve Liapis 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Director Ian Clark 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Director Dan Spiegelman 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Director Beth Spiegelman 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Director Brian Kotzin 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Director Fred Cohen 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Director Biotechnology Decline to Disclose 06b false 2021-11-09 false true true Shares issued in partial consideration the licenses and rights granted to the Company by the investor. false 0 151999981 151999981 0 false 24 0 0 0 false Kyverna Therapeutics, Inc. /s/ Ryan Jones Ryan Jones Chief Financial Officer 2023-11-06